Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
The use of animal models to determine the toxicity of a pharmaceutical, biopharmaceutical or medical device is a required part of evaluating the overall safety of the product and predicting its effects on humans.